544205 — National Peroxide Cashflow Statement
0.000.00%
- IN₹3.69bn
- IN₹3.10bn
- IN₹2.90bn
Annual cashflow statement for National Peroxide, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 535 | 215 | -20.8 | 150 |
| Depreciation | ||||
| Non-Cash Items | 32 | -13.2 | -14.1 | -15.3 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -93.9 | -30.5 | 20.5 | -0.33 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 671 | 364 | 187 | 342 |
| Capital Expenditures | -59.9 | -146 | -48.9 | -44.5 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 308 | -28.8 | 31.6 | -185 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Change in Net Investments | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 248 | -175 | -17.3 | -229 |
| Financing Cash Flow Items | -63 | -27.1 | -15.9 | -13.6 |
| Other Financing Cash Flow | ||||
| Total Cash Dividends Paid | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -860 | -167 | -125 | -53.6 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 59.3 | 21.8 | 43.2 | 58.7 |